Home
>
National Drug Code (NDC)
>
CELEBREX
CELEBREX - 0025-1525-51 - (CELECOXIB)
Drug Information of CELEBREX
| Product NDC: | 0025-1525 |
| Proprietary Name: | CELEBREX |
| Non Proprietary Name: | CELECOXIB |
| Active Ingredient(s): | 200 mg/1 & nbsp; CELECOXIB |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CELEBREX
| Product NDC: | 0025-1525 |
| Labeler Name: | G.D. Searle LLC Division of Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020998 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19981002 |
Package Information of CELEBREX
| Package NDC: | 0025-1525-51 |
| Package Description: | 500 CAPSULE in 1 BOTTLE (0025-1525-51) |
NDC Information of CELEBREX
| NDC Code | 0025-1525-51 |
| Proprietary Name | CELEBREX |
| Package Description | 500 CAPSULE in 1 BOTTLE (0025-1525-51) |
| Product NDC | 0025-1525 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CELECOXIB |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19981002 |
| Marketing Category Name | NDA |
| Labeler Name | G.D. Searle LLC Division of Pfizer Inc |
| Substance Name | CELECOXIB |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
